List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #40,401 to #40,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. PRESENT → Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
  2. PRESERVE → Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
  3. PRESTO → Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
  4. PREVEND IT → Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
  5. PREVENT(Radiation) → Proliferation Reduction With Vascular Energy Trial
  6. PREVENT (Dalteparin) → Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
  7. PREVENT (Warfarin) → Venous thromboembolism
  8. PREVENT II → The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
  9. PREVENT IV → Project Of Ex-Vivo Vein Graft Engineering Via Transfection
  10. PRF1 → Perforin
  11. PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
  12. PRIMA — Presented at ACC.09/i2 → Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
  13. PRIME-2 → Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
  14. PRIMI → Pro-Urokinase For Myocardial Infarction
  15. PRIMO-CABG → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
  16. PRIMO-CABG II → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
  17. PRINCE → Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
  18. PRINCESS → Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
  19. PRINCIPLE-TIMI 44 → The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
  20. PRISM → Platelet-Receptor Inhibition For Ischemic Syndrome Management
  21. PRISM-PLUS → Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
  22. PRISM-Troponin → Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
  23. PRISON II → Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
  24. PRKACB gene → PRKACB
  25. PRKAR1A gene → PRKAR1A
  26. PRL cell adenoma → Prolactinoma
  27. PRL cell tumor → Prolactinoma
  28. PRL secreting adenoma → Prolactinoma
  29. PRL secreting pituitary adenoma → Prolactinoma
  30. PRL tumor → Prolactinoma
  31. PRNT → Plaque reduction neutralization test
  32. PROCAM → Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
  33. PRODH → Proline oxidase
  34. PROFILE → Prospective Randomized Flosequinan Longevity Evaluation
  35. PROGRESS → Perindopril Protection Against Recurrent Stroke Study
  36. PROGRESS-1 → Coronary Stenting With Absorbable Metal Stents
  37. PROLONG study → PROLONG Study
  38. PROM → Premature rupture of membranes
  39. PROMM → Myotonic dystrophy
  40. PROSPER → PROSPER Trial
  41. PROTECT-CAD → Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
  42. PROTECT - TIMI 30 → Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
  43. PROTECT AF → Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation
  44. PROTO oxidase → Protoporphyrinogen oxidase
  45. PROVED → Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
  46. PROVE IT-TIMI 22 (Gatifloxacin) → PROVE IT-TIMI 22 Trial
  47. PROVE IT/TIMI 22 → PROVE IT-TIMI 22 Trial
  48. PROVE IT Trial → PROVE IT-TIMI 22 Trial
  49. PROVIDENCE 1 → Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
  50. PROXIMAL → Proximal Protection During Saphenous Vein Graft Intervention

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"